Pfizer has delivered concerning news to investors by revising its financial projections for both this year and next. The pharmaceutical company announced Tuesday that revenue will likely hit the lower end of its previous guidance for 2025, with an even more sobering outlook for 2026. The adjustments reflect ongoing challenges as the drugmaker attempts to […]

The postPfizer’s troubling forecast reveals major strugglesappeared first onRolling Out.